Planned for genetically engineered TB vaccine
GlaxoSmithKline Plc., Europe's leading drugmaker, and U.S. biotech firm Corixa Corp. said on Wednesday they planned to start the first human tests of a genetically engineered tuberculosis vaccine.
GlaxoSmithKline Plc., Europe's leading drugmaker, and U.S. biotech firm Corixa Corp. said on Wednesday they planned to start the first human tests of a genetically engineered tuberculosis vaccine.